ASTS Vs RKLB: The Market Picked One, Cathie Wood Backed The Other — Which Space Play Won Q2?
Rocket Lab (RKLB) shares fell slightly after Q2 results that included record revenue of $234.07 million, up 62% year over year, and a wider-than-expected loss of $0.08 per share. It guided Q3 revenue to $250 million-$265 million. AST SpaceMobile (ASTS) rose 4% on its results, but reported $31.5 million revenue and a $0.77 loss per share. Analysts cut ASTS targets while raising RKLB targets; ARK bought $23.43 million of RKLB shares.
How this was made
The 30-second read
Why it matters
ASTS faces near-term pressure from a Q2 revenue miss and wider loss, while RKLB’s record revenue and above-consensus guidance are tempered by Neutron development spending and launch timing worries.
Market read
Traders are likely repricing near-term execution and profitability timelines in space infrastructure, with ASTS and RKLB reacting differently to the same earnings cycle.
What to watch
The article notes Iridium acquisition as a potential architecture unlock; if investors re-rate that strategic value, it could offset Neutron timing concerns.
Background
The piece compares Q2 performance of AST SpaceMobile and Rocket Lab, then layers in analyst target changes and ARK fund buying.
Ticker impact
AST SpaceMobile shares rallied after Q2 results, but the article cites a Q2 revenue miss and widened per-share loss, plus reaffirmed 2026 guidance.
Choppy trading likely, with downside risk if investors focus on Q2 miss and loss trajectory despite guidance reaffirmation.
The text provides directionally bearish fundamentals for Q2 (revenue miss, wider loss) while also stating management reaffirmed 2026 revenue guidance, which can limit downside.
Rocket Lab edged lower despite record Q2 revenue and above-consensus guidance, with the article highlighting Neutron spending pressure and potential launch timing slip concerns.
Bias to volatility: rallies on guidance/backlog strength, but pullbacks if launch schedule concerns intensify.
The article includes both positives (record revenue, backlog, Q3 revenue above consensus) and a key overhang (adjusted EBITDA loss range and concerns about Neutron inaugural launch timing).
Market effects
Reinforces that space names are trading on execution risk and near-term profitability, not just revenue growth.
No specific regional market linkage beyond US-listed small/mid-cap growth sentiment.
Limited, as the article focuses on company-specific quarterly performance and guidance.
Counterpoint
RKLB’s guidance and backlog strength may outweigh Neutron schedule fears, making the selloff more sentiment-driven than fundamental.
Key entities
- companyAST SpaceMobile
Reported Q2 revenue of $31.5 million (below consensus) and widened loss per share, while reaffirming 2026 revenue guidance.
- companyRocket Lab
Reported Q2 revenue of $234.07 million (record, above consensus), guided Q3 revenue higher, but flagged Neutron spending and adjusted EBITDA losses.
- asset_managerARK Investment Management
Bought Rocket Lab shares after results across ARK funds, per the article.
- analyst_firmBofA
Lowered ASTS price target to $80 from $95 and kept Neutral rating.
- analyst_firmUBS
Cut ASTS target to $78 from $80 and kept Neutral rating.
